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Light chain effects on alanine and glucose uptake by renal brush border
membranes. Effect of varying concentrations (0 to 800 I.LM) of three
different light chains on sodium—dependent L-('4C)alanine and D-
(14C)glucose uptake by rat renal brush border membrane vesicles were
studied. One , and two A type light chains (A-I and A-2) were isolated
from urines of patients with multiple myeloma. At maximal inhibitory
concentrations the ic chain reduced alanine uptake from 206 18 to 77
18 pmole/mg protein (P < 0.005) and glucose uptake from 357 22
to 146 8 pmole/mg protein (P < 0.001). A-l reduced alanine uptake
from 136 17 to 60 8 pmole/mg protein (P < 0.005) and glucose
uptake from 354 17 to 77 14 pmole/mg protein (P < 0.001). A-2
reduced alanine uptake from 105 9 to 28 5 pmole/mg protein (P <
0.001) and glucose uptake from 194 7 to 66 7 pmole/mg protein (P
<0.001). The half maximal inhibitory concentrations (150) of K, A-l and
A-2 light chains were 68, 76 and 140 M for alanine uptake and 120, 70
and 105 rM for glucose uptake. Control experiments using bovine
serum albumin and /3-lactoglobulin showed no inhibitory effect on
alanine and glucose uptake by either protein. These data reveal brush
border membrane effects by myeloma light chains and confirm that
direct Bence Jones protein nephrotoxicity may play an important role in
the pathogenesis of kidney dysfunction associated with multiple
myeloma.
Renal involvement ranging from Fanconi syndrome to frank
renal failure is common in multiple myeloma [1—7]. Renal
dysfunction associated with myeloma is usually accompanied
by increased urinary excretion of light chains (Bence—Jones
protein). Direct toxicity of light chains to renal tubular cells has,
therefore, been implicated as a major mechanism of renal
dysfunction in multiple myeloma [1, 5—71. The presence of
proximal and distal tubular dysfunction in myeloma patients
[3—71 and demonstration of inhibitory effects of light chains on
rat and rabbit kidney slice uptake of para-amino—hippuric acid
(PAH), tetraethyl ammonium (TEA) and glucose and ammonia
production [8, 9], the inhibition of Na-K ATPase in renal
cortical tubular membranes [101 and induction of tight junctions
in necturus gall bladder [111 leave little room to doubt direct
nephrotoxicity of light chains. While these observations pro-
vide evidence of direct, toxic effects of myeloma light chains on
metabolic and transport processes in the kidney, there are no
studies on the effect of light chains on glucose and amino acid
transport. Since proximal tubular dysfunction is common in
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myeloma, isolated brush border membranes would provide an
appropriate system to investigate the effect of light chains on
proximal tubular transport of glucose and amino acid at the cell
membrane level. We, therefore, isolated and purified light
chains from the urines of three patients with multiple myeloma.
The uptake of L-('4C)alanine and D-('4C)glucose by rat renal
brush border membrane vesicles was then measured with
varying concentrations of purified light chains in the incubation
medium.
Methods
Three different light chains were obtained from urines of
three patients with multiple myeloma. One patient had K light
chain and the other two had A, which will be referred to as
"A-l" and "A-2."
The patient with K light chain was a 62-year—old black male
who presented with bone pains and multiple lytic bone lesions.
At his initial evaluation his BUN was 21 mg/dl, creatinine 3.2
mg/dl and calcium 10.2 mg/dl. His bone marrow aspirate
revealed 36% sheet—forming plasma cells which contained only
K light chain and no other immunoglobulin. Quantitative serum
immunoelectrophoresis showed that immunoglobulin G, A, M
and D levels were all depressed; thus, he was diagnosed as K
chain myeloma. His initial urinary protein excretion was 7.6
glday, 97% of which was 1 light chains. His renal function
declined rapidly and serum calcium levels rose to 11.5 mgldl,
and he died one year later despite chemotherapy.
The patient with A-i light chain was a 56-year—old white male
who had stage III myeloma when he was first diagnosed. He
had IgG myeloma with 50% plasma cells in his bone marrow
aspirate. His initial BUN was 19 mg/dl and creatinine 0.9 mgldl.
He died after one year of chemotherapy, and at the time of
death his BUN was 92 mg/dl and creatinine was 8.6 mg/dl and
his serum calcium 12.4 mg/dl. His urine contained 3.7 g protein,
93% of which was 'y-globulin. He also developed mild glucose
intolerance and at the time of his death his urinalysis revealed
3+ glucose by Multistix (Miles Laboratories, Elkhart, Indiana,
USA) with a simultaneous serum glucose of 222 mg/dl.
The patient with A-2 was a 59-year—old white male diagnosed
as having IgG myeloma. His initial BUN was 30 mg/dl and
creatinine 1.7 mg/dl. His urine contained 3.2 glday protein, 92%
of which was y-globulin.
Light chains were initially precipitated with 70% saturated
ammonium sulfate solution. The precipitate was dissolved in
distilled water and desalted by dialyzing against distilled water
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Fig. 2. L-('4C)alanine (ó) and D-('4C)glucose (d) uptake by brush
border membrane vesicles at 30 seconds with varying concentrations of
K light chain in the medium. The I is 68 M for alanine uptake and 120
/LM for glucose uptake.
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for 24 hours. The concentrated protein solution was further
purified in a Sephadex G-100 column. The eluate was then
lyophilized and stored at —20°C. The identity and purity of the
samples are confirmed by immunoelectrophoresis and poly-
acrylamide SDS gel electrophoresis. All three light chains
appeared more than 95% pure, migrating as a single band in the
24 to 25,000 dalton range in the SDS gel electrophoresis (Fig. 1).
Thus all three light chains studied here were monomeric.
Bovine serum albumin (BSA) with a molecular weight of
approximately 67,000 daltons (Sigma Chemical, St. Louis,
Missouri, USA) and 3-lactoglobulin (BLG) with a molecular
weight of about 35,000 daltons (Miles Scientific, Naperville,
Illinois, USA) were used as controls.
Rat kidney brush border membrane vesicles were prepared
from homogenized renal cortex by the calcium precipitation
method as described previously [12]. Male Sprague—Dawley
rats (Charles River Breeding, Massachusetts, USA) weighing
250 to 300 g were used for vesicle studies.
Effect of light chains on 30 seconds uptake rate of sodium—
dependent L-('4C)alanine and D-('4C)glucose by brush border
membrane vesicle was studied. Brush border membrane frac-
tion of approximately 80 to 150 g protein was incubated in 200
p1 buffer containing either 20 tM L-(14C)alanine or 20 p.M
D-('4C)glucose (New England Nuclear, Boston, Massachusetts,
USA) with varying concentrations of light chains (0, 50, 100,
200, 400, 800 /LM) approximately from 1: 10 to 1:200 weight to
weight light chain to brush border protein ratio in the medium.
These concentrations would be comparable to proximal tubular
concentrations of light chains in a living person. For example,
assuming that light chain was freely filtered, 1 g/dl light chain
would yield 400 p.M of monomeric light chain in the proximal
tubular fluid. At the end of the incubation period, the membrane
preparation was separated from the medium by rapid filtration
technique using 0.45 p.M pore size HAWP filters (Millipore
Corp., Bedford, Massachusetts, USA). Nonspecific retention
of radioactivity was estimated by using control filters treated
identically by filtering 200 p.1 of incubation medium containing
the same amount of radiolabelled alanine or glucose without the
brush border fraction. The filters were dissolved in 8 ml
Aquasol (Dupont-NEN Research Products, Boston, Massachu-
setts, USA) and counted in a liquid scintillation counter.
Uptake of L-(14C)alanine or D-(14C)glucose was defined as total
count less the nonspecific retention of radioactivity. Separate
experiments were performed with BSA and BLG instead of
light chains to rule out a nonspecific protein effect by light
chains on the uptake of L-alanine and D-glucose by renal brush
border membrane vesicles. The amount of alanine or glucose
uptake by brush border membrane was determined in triplicate
and expressed as picomole per mg protein. Protein concentra-
tions were measured by Lowry technique using bovine serum
albumin standards [12].
The half maximal inhibitory concentration (I) of each light
chain was calculated from log dose response curves obtained
with each light chain. Differences between means are evaluated
using the unpaired Student's t-test.
Results
All three light chains inhibited both alanine and glucose
uptake by renal brush border membrane at 30 seconds. At
maximal inhibitory concentration the K light chain reduced
L-('4C)alanine uptake from a control level of 206 18 pmollmg
protein to 77 18 pmol/mg protein (P < 0.001) and D-
(14C)glucose uptake from 357 22 pmol/mg protein to 146 8
pmollmg protein (P < 0.001) (Fig. 2). The I of K lightchain was
calculated as 68 M for alanine uptake and 120 M for glucose
uptake. The A-i light chain decreased alanine uptake from 136
17 to 60 8 pmollmg protein (P < 0.005) and glucose uptake
from 354 17 to 77 14 pmoLlmg protein (P < 0.001) (Fig. 3).
The I5 of this A light chain was 76 p.M for alanine uptake and 70
p.M for glucose uptake. Similarly, the A-2 light chain reduced
alanine uptake from 105 9 to 28 5 pmollmg protein (P <
0.001) and glucose uptake from 194 7 to 66 7 pmollmg
protein (P < 0.001) (Fig. 4). The I5 for the A-2 light chain was
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Fig. 1. SDS-Polyacrylamide gel electrophoresis of the three light
chains. Column 1 is the K chain; 2, A-i and column 3 is A-2. The
right—most column is the standards.
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Fig. 3. L-('4C)alanine () and D-('4C)glucose (d) uptake by brush
border membrane vesicles at 30 seconds with varying concentrations of
A-i light chain in the medium. The I5 is 76 tM foralanine uptake and
70 /iM for glucose uptake.
calculated as 140 tM for alanine uptake and 105 M for glucose
uptake.
Control experiments conducted using 0 to 800 tMconcentra-
tions of /3-lactoglobulin or bovine serum albumin in the incuba-
tion medium revealed no inhibitory effect by either protein on
the uptake of L-('4C)alanine or D-('4C)glucose. The results of
these experiments are shown in Tables 1 and 2.
Discussion
Renal dysfunction is a major cause of morbidity and mortality
in multiple myeloma and may be the first clinical manifestation
of myeloma in as many as two—thirds of cases [1—7]. Renal
involvement in myeloma includes diverse disorders such as
adult Fanconi syndrome (manifested by glycosuria, aminoacid-
uria, phosphaturia, uricosuria, and bicarbonate wasting), uri-
nary concentrating defects, decreased PAH clearance as well as
frank renal failure [1—7]. in most cases, renal dysfunction is
associated with light chain proteinuria and morphologically
correlate with intratubular deposition of light chain containing
casts and presence of intracytoplasmic protein crystals primar-
ily of light chain origin [5, 6, 13—16]. The pathogenesis of renal
disease in myeloma is, therefore, attributed to direct nephro-
toxicity of light chain proteins [5—il, 17, 18]. On the other hand,
the absence of renal dysfunction in some patients with large
amounts of light chain proteinuria suggests variable toxicity of
these proteins. Factors such as hypercaicemia, tumor mass,
bone metastases, and volume depletion may contribute to renal
disease in myeloma and may make it difficult to evaluate the
nephrotoxicity of light chain alone.
Our experiments with the brush border membrane vesicle
preparation permit in vitro evaluation of direct effects of light
chains on renal tubular cell function at the cell membrane level.
Our results revealed that three different light chains (one Kand
two A) obtained from three individuals with myeloma and
varying degrees of renal insufficiency inhibited both alanine and
glucose transport by rat renal brush border membrane vesicles.
Control experiments using BSA and BLG had no inhibitory
effect on either transport system, suggesting a unique toxic
effect by light chains. These observations are in agreement with
previous reports of direct light chain toxicity. Preuss et al
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Fig. 4. L-('4C)alanine () and D-('4C)glucose (d) uptake by brush
border membrane vesicles at 30 seconds with varying concentrations of
A-2 light chain in the medium. The 150 is 140 M for alanine uptake and
105 M for glucose uptake.
observed that light chains in incubation media inhibited PAH
and TEA uptake by rat and rabbit renal cortical slices, and
suppressed glucose and ammonia production [8, 9]. Fine and
Rees, in a letter to the editor, disputed the evidence that Bence
Jones proteins had direct toxicity on the slice system and
reported that purified light chains from two patients had no
inhibitory effect on the slice uptake of TEA [191. Reconciliation
of these discrepant observations would require additional stud-
ies using the slice technique. The slice technique, however,
yields access to the renal tubule only from the antiluminal side
[20, 211. Isolated brush border membrane system would closely
resemble the conditions seen in a patient with light—chain
proteinuria. Our observations are, therefore, different from the
slice experiments in that we have found a specific effect of light
chains on the brush border side.
Light chain toxicity has been observed in other systems as
well. Alavi et al reported epithelial tight junction formation in
the glomerulus of a patient with K light chain proteinuria [Il].
The light chain isolated from this patient's urine was further
shown to increase transepithelial resistance and potential dif-
ference on the mucosal surface of the Necturus gall bladder.
McGeoch et al, on the other hand, showed a direct inhibitory
effect of light chains on ouabain sensitive Na-K ATPase in
plasma membranes obtained from rat renal cortical tubules [101.
The presence of significant Na-K ATPase activity in this
preparation indicates presence of significant quantities of anti-
luminal membrane fragments in this preparation [12]. Thus, this
report pertains to toxicity of light chain on the antiluminal
membrane and may account for the adverse metabolic effects of
light chains in the slice system.
In conclusion, our studies reveal that light chains have direct
toxic effects on the brush border membrane. We observed
direct inhibitory effects of three different light chains obtained
from the urine of patients with myeloma on the uptake of both
alanine and glucose by isolated rat renal brush border mem-
brane vesicles. Absence of inhibitory effects of BSA and BLG
suggests that in our system the inhibitory effects are specific to
myeloma proteins. A direct toxic action of light chains on renal
tubular cell membranes may be an important mechanism in the
pathogenesis of a variety of renal functional abnormalities as
well as renal failure seen in multiple myeloma.
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Table 1. L-(14C)alanine and D-('4C)glucose uptake by brush border membrane vesicles (mean saM) with bovine serum albumin (BSA) in the
mediuma
BSA, tM 0 50 100 200 400 800
Alanine uptake, pmole/mg protein 259 49 380 42 340 126 346 124 387 197 304 90
Glucose uptake, pmole/mg protein 678 180 728 121 967 189 883 163 900 220 879 69
a None of the differences are statistically significant. N = 4 in each uptake.
Table 2. L-('4C)alanine and D-(14C)glucose uptake by brush border membrane vesicles (mean SEM) with 3-lactog1obulin (BLG) in the
mediuma
BSA, iLM 0 100 200 400 800
Alanine uptake, pmole/mg protein 378 261 354 125 456 228 475 303 354 205N= 4
Glucose uptake, pmole/mg protein 198 48 245 39 246 107 266 66 202 42N= 6
a None of the differences are statistically significant.
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